The stock of DENTSPLY Sirona Inc (XRAY) has gone down by -7.46% for the week, with a -11.37% drop in the past month and a -17.26% drop in the past quarter. The volatility ratio for the week is 2.97%, and the volatility levels for the past 30 days are 2.31% for XRAY. The simple moving average for the last 20 days is -8.51% for XRAY stock, with a simple moving average of -16.62% for the last 200 days.
Is It Worth Investing in DENTSPLY Sirona Inc (NASDAQ: XRAY) Right Now?
Additionally, the 36-month beta value for XRAY is 1.07. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 rating it as “hold,” and 1 rating it as “sell.”
The public float for XRAY is 205.59M and currently, short sellers hold a 5.80% ratio of that float. The average trading volume of XRAY on May 06, 2024 was 3.55M shares.
XRAY) stock’s latest price update
The stock of DENTSPLY Sirona Inc (NASDAQ: XRAY) has decreased by -0.32 when compared to last closing price of 28.38. Despite this, the company has experienced a -7.46% fall in its stock price over the last five trading sessions. Seeking Alpha reported 2024-05-02 that DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2024 Results Conference Call May 2, 2024 8:30 AM ET Company Participants Andrea Daley – Vice President-Investor Relations Simon Campion – CEO, President & Director Glenn Coleman – Chief Financial Officer Andreas Frank – Executive Vice President & Chief Business Officer Conference Call Participants David Saxon – Needham & Company Jeff Johnson – Baird Dylan Finley – UBS Elizabeth Anderson – Evercore ISI Jason Bednar – Piper Sandler Jordan Bernstein – Stifel Sarah Conrad – Goldman Sachs Justin Lin – William Blair Allen Lutz – Bank of America Michael Petusky – Barrington Research Erin Wright – Morgan Stanley Operator Good day, everyone. And thank you for standing by.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Leerink Partners repeating the rating for XRAY by listing it as a “Outperform.” The predicted price for XRAY in the upcoming period, according to Leerink Partners is $42 based on the research report published on February 26, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $35. The rating they have provided for XRAY stocks is “Buy” according to the report published on November 16th, 2023.
XRAY Trading at -12.27% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.57% of loss for the given period.
Volatility was left at 2.31%, however, over the last 30 days, the volatility rate increased by 2.97%, as shares sank -12.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.73% lower at present.
During the last 5 trading sessions, XRAY fell by -7.46%, which changed the moving average for the period of 200-days by -30.44% in comparison to the 20-day moving average, which settled at $30.72. In addition, DENTSPLY Sirona Inc saw -20.51% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 10,000 shares at the price of $31.44 back on Nov 22 ’23. After this action, LUCIER GREGORY T now owns 43,121 shares of DENTSPLY Sirona Inc, valued at $314,400 using the latest closing price.
Coleman Glenn, the Executive VP & CFO of DENTSPLY Sirona Inc, purchase 10,000 shares at $29.70 during a trade that took place back on Nov 20 ’23, which means that Coleman Glenn is holding 73,566 shares at $297,000 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.53 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.02. The total capital return value is set at -0.02. Equity return is now at value -2.75, with -1.28 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is -1.13.
Currently, EBITDA for the company is 638.0 million with net debt to EBITDA at 3.98. When we switch over and look at the enterprise to sales, we see a ratio of 1.98. The receivables turnover for the company is 6.01for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.43.
Conclusion
In conclusion, DENTSPLY Sirona Inc (XRAY) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
